文献速递中枢神经肿瘤放疗姑息放疗与转移瘤

NRG Oncology CC001中接受全脑放疗的脑转移患者条件神经认知功能失败风险的探索性分析

An Exploratory Analysis of the Conditional Neurocognitive Function Failure Risk in Patients Receiving Whole Brain Radiation Therapy for Brain Metastases on NRG Oncology CC001.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2024-09-25

该事后分析纳入NRG-CC001中518例脑转移患者,随机接受全脑放疗+美金刚或海马回避全脑放疗+美金刚。全队列6个月神经认知功能失败累积风险为64.0%,条件月风险最高在放疗后2至3个月(0.97),8个月时降至0.036。海马回避放疗和年龄≤61岁在2个月无认知失败生存后仍为保护因素。

要点

  • 全队列6个月神经认知功能失败累积风险为64.0%。
  • 放疗后2至3个月条件月风险最高为0.97,8个月时降至0.036。
  • 2个月无认知失败生存后,海马回避放疗(HR 0.74;P=.033)和年龄≤61岁(HR 0.62;P=.003)仍为保护因素。

核心结论

  • 神经认知毒性风险最高在治疗前3个月内,减轻毒性的策略应关注这一初始时期。
  • 患者保持认知完好的生存时间越长,神经认知损伤的条件风险显著下降。

研究设计与样本

  • 对NRG-CC001中518例脑转移患者进行事后分析,患者随机接受全脑放疗+美金刚或海马回避全脑放疗+美金刚。
  • 采用寿命表法计算条件月风险率,累积发生率法估计神经认知功能失败率,并用病因特异性多变量Cox比例风险模型分析相关因素。

主要发现

  • 全队列6个月神经认知功能失败累积风险为64.0%。
  • 神经认知毒性发展的最高条件月风险率在放疗后2至3个月为0.97(95%CI,0.85-1.10),随后显著下降,至治疗后8个月平台为0.036(95%CI,0-0.11)。
  • 对于2个月无认知失败生存,海马回避全脑放疗(HR 0.74;P=.033)和年龄≤61岁(HR 0.62;P=.003)持续对认知毒性有保护作用。
  • 对于无认知功能障碍生存≥2个月的患者,海马回避技术显著降低神经认知功能失败的条件累积发生率(P=.047)。

临床怎么用

  • 这些数据可用于告知患者其神经认知功能失败风险如何随时间变化。
  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We sought to estimate the conditional risk of development of neurocognitive function failure (NCFF) after whole brain radiation therapy (WBRT) for patients with brain metastases on NRG Oncology CC001. In addition, we aimed to determine if factors prognostic of NCFF at time of treatment remained relevant over time. METHODS AND MATERIALS: We performed a post hoc analysis of 518 patients enrolled on NRG-CC001 in which patients with brain metastases were randomly assigned to WBRT + memantine or hippocampal avoidant (HA-WBRT) + memantine. Life table method was used to calculate conditional monthly hazard rates and cumulative incidence was used to estimate rates of NCFF. Risk factors associated with NCFF were analyzed using cause-specific multivariable Cox proportional hazards modeling. RESULTS: The cumulative risk of development of NCFF by 6 months was 64.0% for the entire cohort. The greatest conditional monthly hazard rate of development of neurocognitive toxicity was 2 to 3 months postradiation (0.97; 95% CI, 0.85-1.10); this rate significantly declined and then plateaued to 0.036 (95% CI, 0-0.11) by 8 months posttreatment. For 2-month survivorship without cognitive failure, HA-WBRT (HR, 0.74; P = .033) and age ≤61 years (HR, 0.62; P = .003) continued to be protective against cognitive toxicity. In addition, conditional cumulative incidence of development of NCFF was significantly reduced with HA techniques for patients living ≥2 months free of cognitive dysfunction (P = .047). CONCLUSIONS: Our data highlight that the greatest risk of development of neurocognitive toxicity is within the first 3 months after treatment, and therefore strategies to mitigate toxicities should focus on this initial period. Moreover, the conditional risk of neurocognitive impairment significantly declines the longer patients live with preserved cognition. Importantly, these data can be used to inform patients on how their risks of development of NCFF can change over time.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Cherng HR, Sun K, Bentzen SM, et al. An Exploratory Analysis of the Conditional Neurocognitive Function Failure Risk in Patients Receiving Whole Brain Radiation Therapy for Brain Metastases on NRG Oncology CC001. Int J Radiat Oncol Biol Phys. 2024. PMID: 39332644. doi:10.1016/j.ijrobp.2024.09.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。